TRADES
Latest Trades
2087
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 27 Oct 2021 Buy VERV VERVE THERAPEUTICS INC 22,150 0.0138
ARKG 27 Oct 2021 Buy VCYT VERACYTE INC 24,400 0.0153
ARKG 27 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 15,089 0.0271
ARKG 27 Oct 2021 Buy EXAS EXACT SCIENCES CORP 83,000 0.1077
ARKG 27 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 52,127 0.0322
ARKG 26 Oct 2021 Buy VERV VERVE THERAPEUTICS INC 1,656 0.0010
ARKG 26 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 81,645 0.3601
ARKG 26 Oct 2021 Buy VCYT VERACYTE INC 31,300 0.0198
ARKG 26 Oct 2021 Buy SLGC SOMALOGIC INC 49,739 0.0078
ARKG 26 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 18,200 0.0329
ARKG 26 Oct 2021 Buy EXAS EXACT SCIENCES CORP 26,180 0.0339
ARKG 26 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 14,525 0.0089
ARKG 25 Oct 2021 Buy VERV VERVE THERAPEUTICS INC 3,208 0.0020
ARKG 25 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 30,704 0.1375
ARKG 25 Oct 2021 Buy VCYT VERACYTE INC 1,324 0.0008
ARKG 25 Oct 2021 Buy SLGC SOMALOGIC INC 69,610 0.0111
ARKG 25 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 3,535 0.0065
ARKG 25 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 67,105 0.0416
ARKG 22 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 32,819 0.1455
ARKG 22 Oct 2021 Buy VCYT VERACYTE INC 19,400 0.0123
ARKG 22 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 30,000 0.0031
ARKG 22 Oct 2021 Buy SLGC SOMALOGIC INC 216,800 0.0343
ARKG 22 Oct 2021 Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 267,412 0.0947
ARKG 22 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 16,492 0.0297
ARKG 22 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 51,008 0.0307
ARKG 21 Oct 2021 Buy VCYT VERACYTE INC 6,714 0.0043
ARKG 21 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 2,122 0.0002
ARKG 21 Oct 2021 Buy SLGC SOMALOGIC INC 225,026 0.0357
ARKG 21 Oct 2021 Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 17,860 0.0063
ARKG 21 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 4,790 0.0029
ARKG 20 Oct 2021 Buy VCYT VERACYTE INC 11,293 0.0073
ARKG 20 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 700 0.0001
ARKG 20 Oct 2021 Buy SLGC SOMALOGIC INC 20,700 0.0033
ARKG 19 Oct 2021 Buy VEEV VEEVA SYSTEMS INC 13,685 0.0617
ARKG 19 Oct 2021 Sell VCYT VERACYTE INC 300 0.0002
ARKG 19 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 11,570 0.0013
ARKG 18 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 8,844 0.0395
ARKG 18 Oct 2021 Buy VCYT VERACYTE INC 210 0.0001
ARKG 18 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 103,053 0.0112
ARKG 18 Oct 2021 Buy SLGC SOMALOGIC INC 50,800 0.0083
ARKG 18 Oct 2021 Buy QSI QUANTUM-SI INC 202,252 0.0244
ARKG 15 Oct 2021 Buy VCYT VERACYTE INC 42,500 0.0269
ARKG 15 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 628 0.0001
ARKG 15 Oct 2021 Buy SLGC SOMALOGIC INC 256,920 0.0410
ARKG 15 Oct 2021 Sell REGN REGENERON PHARMACEUTICALS INC 13,078 0.1014
ARKG 15 Oct 2021 Buy QSI QUANTUM-SI INC 82,166 0.0099
ARKG 15 Oct 2021 Sell NSTG NANOSTRING TECHNOLOGIES INC 153,997 0.0952
ARKG 14 Oct 2021 Buy VCYT VERACYTE INC 603 0.0004
ARKG 14 Oct 2021 Buy SLGC SOMALOGIC INC 197,172 0.0325
ARKG 14 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 55,000 0.0079
ARKG 13 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 81,531 0.3513
ARKG 13 Oct 2021 Buy VCYT VERACYTE INC 11,037 0.0069
ARKG 13 Oct 2021 Buy SLGC SOMALOGIC INC 399,610 0.0663
ARKG 13 Oct 2021 Buy QSI QUANTUM-SI INC 19,900 0.0025
ARKG 13 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 51,559 0.0943
ARKG 13 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 577 0.0001
ARKG 13 Oct 2021 Buy CRSP CRISPR THERAPEUTICS AG 150,210 0.2073
ARKG 12 Oct 2021 Sell VRTX VERTEX PHARMACEUTICALS INC 39,536 0.1057
ARKG 12 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 15,882 0.0675
ARKG 12 Oct 2021 Buy VCYT VERACYTE INC 200 0.0001
ARKG 12 Oct 2021 Buy TDOC TELADOC HEALTH INC 83,532 0.1618
ARKG 12 Oct 2021 Sell TAK TAKEDA PHARMACEUTICAL CO LTD 244,650 0.0511
ARKG 12 Oct 2021 Buy SLGC SOMALOGIC INC 287,665 0.0487
ARKG 12 Oct 2021 Buy QSI QUANTUM-SI INC 80,290 0.0102
ARKG 12 Oct 2021 Sell NSTG NANOSTRING TECHNOLOGIES INC 77,452 0.0498
ARKG 12 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 5 0.0000
ARKG 12 Oct 2021 Buy CDNA CAREDX INC 79,253 0.0770
ARKG 12 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 15,167 0.0198
ARKG 12 Oct 2021 Buy ARCT ARCTURUS THERAPEUTICS HOLDINGS INC 115,000 0.0758
ARKG 11 Oct 2021 Sell VRTX VERTEX PHARMACEUTICALS INC 20,600 0.0546
ARKG 11 Oct 2021 Sell VEEV VEEVA SYSTEMS INC 1,702 0.0072
ARKG 11 Oct 2021 Sell TAK TAKEDA PHARMACEUTICAL CO LTD 17,654 0.0037
ARKG 11 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 3,810 0.0005
ARKG 11 Oct 2021 Buy SLGC SOMALOGIC INC 171,826 0.0286
ARKG 11 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 12,600 0.0093
ARKG 11 Oct 2021 Sell REGN REGENERON PHARMACEUTICALS INC 24,941 0.2034
ARKG 11 Oct 2021 Buy QSI QUANTUM-SI INC 44,724 0.0055
ARKG 11 Oct 2021 Sell EDIT EDITAS MEDICINE INC 100,357 0.0540
ARKG 11 Oct 2021 Buy CRSP CRISPR THERAPEUTICS AG 65,292 0.0961
ARKG 11 Oct 2021 Buy CDNA CAREDX INC 27,844 0.0261
ARKG 11 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 23,872 0.0298
ARKG 8 Oct 2021 Buy TDOC TELADOC HEALTH INC 12,496 0.0235
ARKG 8 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 75,405 0.0083
ARKG 8 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 79,461 0.0094
ARKG 8 Oct 2021 Buy SLGC SOMALOGIC INC 21,202 0.0035
ARKG 8 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 10,905 0.0081
ARKG 8 Oct 2021 Buy QSI QUANTUM-SI INC 112,210 0.0135
ARKG 8 Oct 2021 Buy NTLA INTELLIA THERAPEUTICS INC 106,395 0.1861
ARKG 8 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 1,005 0.0001
ARKG 8 Oct 2021 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,535,517 0.2312
ARKG 8 Oct 2021 Buy CRSP CRISPR THERAPEUTICS AG 136,060 0.1932
ARKG 8 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 37,753 0.0455
ARKG 8 Oct 2021 Buy ACCD ACCOLADE INC 347,467 0.1967
ARKG 7 Oct 2021 Sell VRTX VERTEX PHARMACEUTICALS INC 17,828 0.0500
ARKG 7 Oct 2021 Buy TDOC TELADOC HEALTH INC 81,837 0.1600
ARKG 7 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 57,717 0.0100
ARKG 7 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 8,272,712 0.9000
ARKG 7 Oct 2021 Buy SLGC SOMALOGIC INC 250,800 0.0400
ARKG 7 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 40,180 0.0300
ARKG 7 Oct 2021 Buy QSI QUANTUM-SI INC 23,401 0.0000
Latest Blogs
Is Cathie Wood's winning streak coming to an end? In the third quarter, Ark Invest ETFs underperformed a broader market

Even while other actively managed funds and fund managers battled to recover from the COVID-19-induced slowdown, Cathie Wood's Ark Invest had a spectacular year in 2020. Wood was dubbed the "Midas Touch" after her fund's flagship ARK Innovation ETF ARKK +0.77% (Get Free Alerts for ARKK) returned a whopping 153 percent, outperforming the S& P 500 Index's 16.3 percent gain.

Ark Experiences a Post-COVID-19 Complication: By 2021, Ark's performance had become more mixed. The Ark Innovation ETF dropped 3.7 percent in the first quarter before rebounding with a 9 percent gain in the second.

According to Ark's third-quarter performance report, all of its actively managed funds and its two self-indexed ETFs underperformed the market.

The performance of each Ark ETF in the third quarter is as follows:

 

ETFs that are actively traded

ETF: Ark Innovation: (-15.5 percent )

The Ark Autonomous Technology & Robotics ETF (ARKQ) is an exchange-traded fund that invests in autonomous technology and robotics (-9.5 percent )

The Ark Next Generation Internet ETF (ARKW) is an exchange-traded fund that invests in the next generation of the internet (-9.9 percent )

ETF for the Ark Genomic Revolution (ARKG): (-19.3 percent )

ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARK (-8.7 percent )

ARK Space Exploration & Innovation ETF (ARKX): Ark ETF Trust: (-6.6 percent )

ETFs that track indices

The ETF for 3D Printing (PRNT): (-10 percent )

The Ark Israel Innovation Technology ETF (IZRL) is a mutual fund that invests in Israel's innovative technology (-8.3 percent )

When compared to the more significant market performance, the low showing is exemplified. The S& P 500 Index rose 2.5 percent in the third quarter, while the Nasdaq Composite Index rose 5.1 percent.

Consumer and investor confidence is being harmed by macro headwinds, according to Wood's quarterly report. Fears of an economic slowdown arose due to a spike in the delta strain of the coronavirus, supply chain difficulties, and a Chinese government crackdown, she noted.

Ark feels that inflation fears are exaggerated and that the chances of deflation are more plausible.

Will Bitcoin Be Banned In The United States Like Gold Was? Cathie Wood and Ark Invest weigh in.

 

Tesla Aids In Weakness Mitigation: Wood is a self-proclaimed Tesla, Inc. TSLA +3.26 percent bull. With over 10% stakes in each, Tesla is part of the ARK Innovation ETF, the Ark Innovation ETF, and the Ark Innovation ETF.

In the third quarter, the electric vehicle behemoth topped the list of contributors to the returns of each of these ETFs.

Ark Invest sold approximately $605 million of Tesla stock in September alone, taking advantage of the EV maker's third-quarter rally.

Tesla's sales have continued far into October.

Energy and financial services are the most likely to be disrupted by innovation. The power and financial services sectors have benefited the most from the shift toward cyclical in the last nine to 12 months, according to Ark. These two industries, according to the firm, will be the most disrupted by innovation during the next five years.

"Autonomous electric vehicles and digital wallets, including cryptocurrencies and the decentralized financial services (DeFi) associated more broadly with blockchain technologies, will, in ARK's opinion, significantly disrupt and disintermediate both Energy and Financial Services over the next five years."

 

Cathie Wood, the founder of Ark Invest, did not purchase the first Bitcoin futures ETF.

According to Business Insider, Ark Invest founder and CEO Cathie Wood did not invest in the ProShares Bitcoin Strategy exchange-traded fund (ETF) on its first day.

Wood had this to say regarding the ETF's debut:

"We did not [invest]," says the narrator. We're taking a close look at this [...] there are specific tax implications we'd like to learn more about in terms of contango versus more traditional backwardation."

When the future price is greater than the current price, the ETF is in contango. In a negative trend, backwardation occurs when the forward price of a futures contract is lower than the spot price.

In June, wood's Ark Invest teamed up with 21 Shares to file for its Bitcoin (BTC) ETF. When it comes to investing in cryptocurrencies, she is also no stranger to the stock market.

Ark Investment Management, one of her funds, has been permitted to invest in Canada's Bitcoin ETF, the Ark Next Generation ETF. Grayscale Bitcoin Trust (GBTC) has 8.3 million shares, with Bitcoin and Ether (ETH) accounting for a significant portion of Ark Invest's portfolio.

Ark Invest also added Coinbase stock to three of its ETFs in the spring, including the Ark Innovation ETF (ARKK), the Ark Next Generation Internet ETF (ARKW), and the Ark Fintech Innovation ETF (ARKF).

Wood stated that she is on the lookout for the next FAANG investment that will benefit her investors. FAANG is an abbreviation for the five largest American technology companies: Facebook, Amazon, Apple, Netflix, and Google. Jim Cramer first invented the phrase "FAANG" in 2013.

On its first day of trading, the Bitcoin Strategy ETF recorded the highest natural volume of any ETF and the second-highest overall volume.

 

Cathie Wood's Ark Invest is leaving Wall Street and relocating to Florida

Ark Investment Management said on Wednesday that it is permanently closing its New York office and relocating to St. Petersburg, Florida.

In 2020, Wood's flagship Ark Innovation exchange-traded fund soared over 150 percent, making her a Wall Street sensation.

Wood is unique in that she focuses solely on the technology industry. So it's probably unsurprising that she's quitting Wall Street.

Ark expects the move to "advance its business as it scales and continues to alter the asset management market," as well as "improve collaboration between and across the communities focused on innovation," according to the company.

"Ark isn't your typical Wall Street asset management firm, and we're excited to continue to break the mold by relocating to St. Petersburg, a city that values technology, research, and creativity," Wood added.

Jana Haines, Ark's strategy chief, said the area's "vibrant and diversified talent base" and the success of public-private partnerships centered on innovation encouraged the company.

This year hasn't been as good to Wood as the previous one. Despite a booming tech market, with the Nasdaq up more than 14 percent so far in 2021, the Innovation ETF is down 3.5 percent coming into the fourth quarter.